Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Randomized Multicenter Study of Once Daily Antiretroviral Treatment Regimen Comparing Ritonavir Boosted Atazanavir to Efavirenz

NCT00280969 is registered in ClinicalTrials.gov with International Medical Center of Japan as lead sponsor.

NCT NCT00280969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Randomized Multicenter Study of Once Daily Antiretroviral Treatment Regimen Comparing Ritonavir Boosted Atazanavir to Efavirenz
Lead sponsor
International Medical Center of Japan
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2009
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection